It is only necessary to inject concentrated sugar to prevent the occurrence of hypoglycemia, and the dose of 6 IU/h of continuous intravenous pumped insulin is approximately the same as that of 1.0 IU/kg intraperitoneal injection in mice and 100 nM conversion in A549 and ATII cells, so the clinical results are highly consistent with the results of animal and cellular experiments. The gene discussed is INS; the disease is Hypoglycemia.